Page last updated: 2024-10-30

beta-lapachone and Carotid Arteriopathies, Traumatic

beta-lapachone has been researched along with Carotid Arteriopathies, Traumatic in 1 studies

beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, SY1
Jeoung, NH1
Oh, CJ1
Choi, YK1
Lee, HJ1
Kim, HJ1
Kim, JY1
Hwang, JH1
Tadi, S1
Yim, YH1
Lee, KU1
Park, KG1
Huh, S1
Min, KN1
Jeong, KH1
Park, MG1
Kwak, TH1
Kweon, GR1
Inukai, K1
Shong, M1
Lee, IK1

Other Studies

1 other study available for beta-lapachone and Carotid Arteriopathies, Traumatic

ArticleYear
Activation of NAD(P)H:quinone oxidoreductase 1 prevents arterial restenosis by suppressing vascular smooth muscle cell proliferation.
    Circulation research, 2009, Apr-10, Volume: 104, Issue:7

    Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals

2009